- Accesswire•11 hours agoSHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016
NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals Inc. ("Spectrum" ...
- Business Wire•14 hours ago
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a teleconference and webcast with management to discuss the third quarter 2016 financial results, provide an update on the Company's business, and discuss expectations for the future.
- Accesswire•yesterdaySHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 - SPPI
NEW YORK, NY / ACCESSWIRE / October 26, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, ...
Spectrum Pharmaceuticals, Inc. (SPPI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||3.73 x 100|
|Ask||6.20 x 1000|
|Day's Range||3.72 - 3.87|
|52wk Range||3.61 - 7.74|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.39|
|Avg Vol (3m)||843,069|
|Dividend & Yield||0.00 (0.00%)|